{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:03:53Z","timestamp":1790370233037,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.euo.2026.09.009","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:37:13Z","timestamp":1790368633000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Individualized Oncologic Surveillance After Radical Prostatectomy for Localized Prostate Cancer"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7828-6876","authenticated-orcid":false,"given":"Francesco","family":"Pellegrino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1152-3005","authenticated-orcid":false,"given":"Ugo Giovanni","family":"Falagario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Abbadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Camilloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Akre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Eklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Nordstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Gr\u00f6nberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter N.","family":"Wiklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2026.09.009_b0005","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.eururo.2024.04.010","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II-2024 update: treatment of relapsing and metastatic prostate cancer","volume":"86","author":"Tilki","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.09.009_b0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/JU.0000000000002758","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, Part II: principles of active surveillance, principles of surgery, and follow-up","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2026.09.009_b0015","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa1615869","article-title":"Follow-up of prostatectomy versus observation for early prostate cancer","volume":"377","author":"Wilt","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2026.09.009_b0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00345-026-06231-5","article-title":"Time to BCR and cancer-specific mortality after radiotherapy or prostatectomy: implications for risk stratification and follow-up","volume":"44","author":"Pellegrino","year":"2026","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2026.09.009_b0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejca.2015.11.004","article-title":"Predicting survival of men with recurrent prostate cancer after radical prostatectomy","volume":"54","author":"Dell\u2019Oglio","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.euo.2026.09.009_b0030","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.eururo.2013.03.006","article-title":"Survival following biochemical recurrence after radical prostatectomy and adjuvant radiotherapy in patients with prostate cancer: the impact of competing causes of mortality and patient stratification","volume":"64","author":"Abdollah","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.09.009_b0035","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.eururo.2007.01.015","article-title":"Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy","volume":"51","author":"Simmons","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.09.009_b0040","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.euo.2025.05.026","article-title":"Epidemiology of high-risk biochemical recurrence after primary prostate cancer treatment","volume":"8","author":"Falagario","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2026.09.009_b0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.euf.2019.06.004","article-title":"Biochemical recurrence in prostate cancer: the European Association of Urology prostate cancer guidelines panel recommendations","volume":"6","author":"Van den Broeck","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2026.09.009_b0050","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.eururo.2018.10.011","article-title":"Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review","volume":"75","author":"Van den Broeck","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.09.009_b0055","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJMoa2303974","article-title":"Improved outcomes with enzalutamide in biochemically recurrent prostate cancer","volume":"389","author":"Freedland","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2026.09.009_b0060","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.eururo.2019.03.016","article-title":"External validation of the European Association of Urology biochemical recurrence risk groups to predict metastasis and mortality after radical prostatectomy in a European cohort","volume":"75","author":"Tilki","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.09.009_b0065","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyaf062","article-title":"Data resource profile: STHLM0, the Stockholm prostate cancer diagnostics register","volume":"54","author":"Abbadi","year":"2025","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.euo.2026.09.009_b0070","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.281.17.1591","article-title":"Natural history of progression after PSA elevation following radical prostatectomy","volume":"281","author":"Pound","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.euo.2026.09.009_b0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/21681805.2020.1739139","article-title":"Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden","volume":"54","author":"Aly","year":"2020","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euo.2026.09.009_b0080","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","article-title":"The Swedish cause of death register","volume":"32","author":"Brooke","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.euo.2026.09.009_b0085","doi-asserted-by":"crossref","first-page":"830.e17","DOI":"10.1016\/j.urolonc.2021.04.031","article-title":"Radical prostatectomy for localized prostate cancer: 20-year oncological outcomes from a German high-volume center","volume":"39","author":"W\u00fcrnschimmel","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2026.09.009_b0090","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.euo.2023.11.021","article-title":"Assessing the impact of positive surgical margins on mortality in patients who underwent robotic radical prostatectomy: 20 years\u2019 report from the EAU robotic urology section Scientific Working Group","volume":"7","author":"Pellegrino","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2026.09.009_b0095","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0197-2456(03)00072-2","article-title":"On the use and utility of the Weibull model in the analysis of survival data","volume":"24","author":"Carroll","year":"2003","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.euo.2026.09.009_b0100","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1200\/JCO.2015.61.8009","article-title":"Oncologic surveillance after surgical resection for renal cell carcinoma: a novel risk-based approach","volume":"33","author":"Stewart-Merrill","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2026.09.009_b0105","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.euo.2022.04.003","article-title":"Oncologic surveillance after radical nephroureterectomy for high-risk upper tract urothelial carcinoma","volume":"5","author":"Martini","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2026.09.009_b0110","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.eururo.2025.02.020","article-title":"European Association of Urology guidelines on renal cell carcinoma: the 2025 update","volume":"87","author":"Bex","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.09.009_b0115","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.eururo.2025.02.023","article-title":"European Association of Urology guidelines on upper urinary tract urothelial carcinoma: summary of the 2025 update","volume":"87","author":"Masson-Lecomte","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.09.009_b0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00345-022-04245-3","article-title":"Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomy","volume":"41","author":"Blas","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2026.09.009_b0125","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/biomedicines11030727","article-title":"Identifying patients in whom the follow-up scheme after robot-assisted radical prostatectomy could be optimized in the first year after surgery: reducing healthcare burden","volume":"11","author":"Veerman","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.euo.2026.09.009_b0130","doi-asserted-by":"crossref","first-page":"341.e9","DOI":"10.1016\/j.urolonc.2018.04.003","article-title":"Establishment of the optimal follow-up schedule after radical prostatectomy","volume":"36","author":"Matsumoto","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2026.09.009_b0135","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s10147-020-01676-z","article-title":"External validation of the \u201coptimal PSA follow-up schedule after radical prostatectomy\u201d in a new cohort","volume":"25","author":"Yanai","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.euo.2026.09.009_b0140","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.euo.2025.02.013","article-title":"Risk-based prostate-specific antigen monitoring reduces follow-up burden after radical prostatectomy","volume":"8","author":"Paulino Pereira","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2026.09.009_b0145","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.32900","article-title":"Biochemical recurrence and risk of mortality following radiotherapy or radical prostatectomy","volume":"6","author":"Falagario","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euo.2026.09.009_b0150","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7196189","article-title":"Long-term follow-up after prostatectomy for prostate cancer and the need for active monitoring","volume":"2020","author":"Swanson","year":"2020","journal-title":"Prostate Cancer"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126002579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126002579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:37:17Z","timestamp":1790368637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931126002579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"alternative-id":["S2588931126002579"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2026.09.009","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Individualized Oncologic Surveillance After Radical Prostatectomy for Localized Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2026.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}